Skip to main content
Premium Trial:

Request an Annual Quote

NeoGenesis, Tranzyme Expand Therapeutic Discovery Collaboration

NEW YORK, Nov. 25 (GenomeWeb News) - Tranzyme and NeoGenesis Pharmaceuticals said today that they have expanded a therapeutic discovery collaboration that began in August 2001.

Under the expanded collaboration, NeoGenesis will provide additional sets of disease-associated gene sequences of therapeutic interest, and Tranzyme will deliver these genes into different mammalian cell lines and express the proteins using its protein expression technology TExT (Trans Expression Technology). NeoGenesis will use the purified proteins in its ALIS (Automated Ligand Identification System) high-capacity screening platform to discover novel leads for therapeutic intervention.

Further terms of the collaboration were not disclosed.

The Scan

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.

TB Resistance Insights Gleaned From Genome Sequence, Antimicrobial Response Assays

Researchers in PLOS Biology explore M. tuberculosis resistance with a combination of sequencing and assays looking at the minimum inhibitory concentrations of 13 drugs.

Mendelian Disease Genes Prioritized Using Tissue-Specific Expression Clues

Mendelian gene candidates could be flagged for further functional analyses based on tissue-specific transcriptome and proteome profiles, a new Journal of Human Genetics paper says.

Single-Cell Sequencing Points to Embryo Mosaicism

Mosaicism may affect preimplantation genetic tests for aneuploidy, a single-cell sequencing-based analysis of almost three dozen embryos in PLOS Genetics finds.